Barnes Wealth Management Group, Inc Gilead Sciences, Inc. Transaction History
Barnes Wealth Management Group, Inc
- $156 Billion
- Q1 2025
A detailed history of Barnes Wealth Management Group, Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Barnes Wealth Management Group, Inc holds 3,598 shares of GILD stock, worth $387,216. This represents 0.26% of its overall portfolio holdings.
Number of Shares
3,598
Previous 3,651
1.45%
Holding current value
$387,216
Previous $337 Million
19.55%
% of portfolio
0.26%
Previous 0.23%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,289Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.6 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.41 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.88 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.76 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $135B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...